The Alzheimer Society of Ontario joins the over 282,000 Ontarians living with dementia in welcoming yesterday’s submission of lecanemab (brand name Leqembi), a treatment for Alzheimer’s disease already approved for use in the United States, to Health Canada for its consideration and possible approval for use in Canada.
Global News Morning Kingston
New treatment for Alzheimer’s disease could help thousands of Canadians
More Videos
-
NASA unveils it’s latest image from the James Webb telescope
-
St. Lawrence Parks Commission shares some exciting events to keep you busy this summer
-
Kingston’s own Hammer Thrower Jillian Weir speaks about her success in the sport and the OLG’s campaign “Quest for Gold”
-
Nutritious Snacks for the Summer Season
-
Real Estate Statistics for the Month of June in the Greater Kingston Area
-
Bill Welychka speaks with GNM about Luscious, Empire RockFest and a special 60th birthday bash!
You are viewing an Accelerated Mobile Webpage.
View Original Article